ScienceThe SaaS Newsabout 2 hours ago
Inocras Raises $31M Series B-3
2 min read
San Diego bioinformatics firm Inocras raised $31 million in an oversubscribed Series B-3, bringing total funding to about $100 million. Investors include NDS Corporation, Aimed Bio, and InterVest. The capital will expand U.S. commercial infrastructure for its CancerVision and MRDVision platforms.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
